Evaluation of single and multiple doses of a novel mGlu2 agonist, a potential antipsychotic therapy, in healthy subjects. [electronic resource]
Producer: 20180412Description: 1654-1667 p. digitalISSN:- 1365-2125
- Administration, Oral
- Adult
- Aged
- Area Under Curve
- Bridged Bicyclo Compounds -- blood
- Cohort Studies
- Disorders of Excessive Somnolence -- chemically induced
- Dizziness -- chemically induced
- Dose-Response Relationship, Drug
- Double-Blind Method
- Half-Life
- Headache
- Healthy Volunteers
- Humans
- Male
- Middle Aged
- Nausea -- chemically induced
- Placebos
- Prodrugs -- pharmacology
- Receptors, Metabotropic Glutamate -- agonists
- Triazoles -- blood
- Vomiting -- chemically induced
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.